Xcell Therapeutics, Inc. (373110.KQ) Stock Price, Financials & Summary | drillr

Skip to content

Sign in Sign up

Price chart

Aug 20Aug 25Aug 28Sep 2Sep 7Sep 10Sep 15Sep 18

Key dataSep 18, 2026

OpenKRW 1,018.00

From 52W high−64.84%

Volume55137.00

Market capKRW 14.14B

P/E (TTM)—

P/S (TTM)3.2x

Div yield—

Key dataSep 18, 2026

Open

KRW 1,018.00

From 52W high

−64.84%

Volume

55137.00

Market cap

KRW 14.14B

ValuationView details →

P/E (Fwd)

—

EV/EBITDA

−1.6x

P/E (TTM)

—

RSI (14)

35.2

MomentumView details →

1D Return

−0.10%

YTD Return

−38.77%

ValuationView details →

P/E (Fwd)

—

P/E (TTM)

—

EV/EBITDA

−1.6x

EV/Sales

3.5x

P/S (TTM)

3.2x

P/B (TTM)

3.3x

ProfitabilityView details →

Gross Margin

−48.21%

Net Margin

−252.44%

EBITDA Margin

−223.10%

ROE (TTM)

−254.54%

ROA (TTM)

−87.21%

Asset Turnover

0.32x

GrowthView details →

Revenue YoY

+193.70%

EPS YoY

+23.37%

FCF YoY

−9.31%

Revenue CAGR 3Y

+24.09%

EPS CAGR 3Y

−7.32%

EBITDA YoY

−53.46%

MomentumView details →

1D Return

−0.10%

YTD Return

−38.77%

1Y Return

−64.74%

RSI (14)

35.2

vs 50D SMA

−13.00%

vs 200D SMA

−29.12%

Capital & dividendView details →

Debt/Equity

1.24x

Current Ratio

1.28x

Quick Ratio

1.07x

Div Yield

—

Div Rate

—

Div Growth 1Y

—

EarningsView details →

EPS (Actual)

—

EPS Surprise

—

Beats (12Q)

—

Next Q EPS Est

—

Avg Surprise (4Q)

—

Rev Surprise

—

Financials snapshotView financials →

Revenue (TTM)

4.36B

Net Income (TTM)

−11.01B

Op. CF (TTM)

−10.25B

Latest newsMore news →

No recent news for 373110.KQ.

Similar companies

Summit Therapeutics Inc.SMMT Exelixis, Inc.EXEL 生物股份600201.SH 迈威生物-U688062.SH BridgeBio Pharma, Inc.BBIO Duality Biotherapeutics, Inc.09606.HK Find similar companies →

Latest newsMore news →

No recent news for 373110.KQ.